Abstract:Myocardial damage is the most serious pathological consequence of cardiovascular diseases and an important reason for their high mortality. In recent years, because of the high prevalence of systemic energy metabolism disorders (e.g., obesity, diabetes mellitus, and metabolic syndrome), complications of myocardial damage caused by these disorders have attracted widespread attention. Energy metabolism disorders are independent of traditional injury-related risk factors, such as ischemia, hypoxia, trauma, and infection. An imbalance of myocardial metabolic flexibility and myocardial energy depletion are usually the initial changes of myocardial injury caused by energy metabolism disorders, and abnormal morphology and functional destruction of the mitochondria are their important features. Specifically, mitochondria are the centers of energy metabolism, and recent evidence has shown that decreased mitochondrial function, caused by an imbalance in mitochondrial quality control, may play a key role in myocardial injury caused by energy metabolism disorders. Under chronic energy stress, mitochondria undergo pathological fission, while mitophagy, mitochondrial fusion, and biogenesis are inhibited, and mitochondrial protein balance and transfer are disturbed, resulting in the accumulation of nonfunctional and damaged mitochondria. Consequently, damaged mitochondria lead to myocardial energy depletion and the accumulation of large amounts of reactive oxygen species, further aggravating the imbalance in mitochondrial quality control and forming a vicious cycle. In addition, impaired mitochondria coordinate calcium homeostasis imbalance, and epigenetic alterations participate in the pathogenesis of myocardial damage. These pathological changes induce rapid progression of myocardial damage, eventually leading to heart failure or sudden cardiac death. To intervene more specifically in the myocardial damage caused by metabolic disorders, we need to understand the specific role of mitochondria in this context in detail. Accordingly, promising therapeutic strategies have been proposed. We also summarize the existing therapeutic strategies to provide a reference for clinical treatment and developing new therapies.

Mitochondrial dysfunction: roles in skeletal muscle atrophy

The role of mitochondrial dynamics and mitophagy in skeletal muscle atrophy: from molecular mechanisms to therapeutic insights

Targeting Mitochondrial Quality Control in Muscle Aging: Natural Dietary Products As Potential Interventions

Oxidative stress: roles in skeletal muscle atrophy

Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging

Potential Therapeutic Strategies for Skeletal Muscle Atrophy

Skeletal muscle mitochondrial remodeling in heart failure: An update on mechanisms and therapeutic opportunities

Skeletal muscle atrophy: From mechanisms to treatments

Mitochondrial dysfunction: mechanisms and advances in therapy

Nutritional Strategies for Muscle Atrophy: Current Evidence and Underlying Mechanisms

Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches

Exploring the Role of Oxidative Stress in Skeletal Muscle Atrophy: Mechanisms and Implications

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease

Skeletal muscle mitochondrial remodeling in exercise and diseases

Mitochondrial Dysfunction of Skeletal Muscular Atrophy Induced with Hindlimb Unloaded.

The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy

Diabetic Muscular Atrophy: Molecular Mechanisms and Promising Therapies

Mitochondria in health, disease, and aging

Cellular and molecular mechanism of skeletal muscle atrophy and anti-atrophic muscle training

Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials